STAT

Could the world see a resurgence of polio? Experts fear a cautionary tale in measles

The resurgence of measles has become a cautionary tale — both useful and unsettling — of why the polio campaign must push on across the finish line, officials say.
A health worker administers polio vaccine in Karachi, Pakistan.

As measles case counts have exploded around the globe this year, public health officials doggedly trying to rid the world of another disease scourge have watched the numbers rise with some concern.

That disease is polio, and for the people who have long worked to eradicate it, the resurgence of measles has become a cautionary tale — both useful and unsettling — of why the polio campaign must push on across the finish line. Failure to do so could have dire consequences.

“In my opinion, there’s no doubt if we stopped the extra efforts we do for polio, we’d have a big resurgence,” said Dr. Walter Orenstein, associate director of Emory University’s Vaccine Center and a consultant to the Global Polio Eradication Initiative.

The effort to eradicate polio is

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.

Related Books & Audiobooks